These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 12591020

  • 1. Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.
    Yatsu T, Sanagi M, Fujimori A, Tomura Y, Hayashi K, Tanahashi M, Inagaki O.
    Pharmacol Res; 2003 Mar; 47(3):243-52. PubMed ID: 12591020
    [Abstract] [Full Text] [Related]

  • 2. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G.
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [Abstract] [Full Text] [Related]

  • 3. Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats.
    Vettoretti S, Vavrinec P, Ochodnicky P, Deelman LE, De Zeeuw D, Henning RH, Buikema H.
    Am J Physiol Renal Physiol; 2016 May 01; 310(10):F1047-53. PubMed ID: 26911850
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
    Windt WA, van Dokkum RP, Kluppel CA, Jeronimus-Stratingh CM, Hut F, de Zeeuw D, Henning RH.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):231-40. PubMed ID: 18036585
    [Abstract] [Full Text] [Related]

  • 5. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L.
    Srp Arh Celok Lek; 2002 Feb 02; 130(3-4):73-80. PubMed ID: 12154518
    [Abstract] [Full Text] [Related]

  • 6. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G.
    Kidney Int; 2002 May 02; 61(5):1635-45. PubMed ID: 11967013
    [Abstract] [Full Text] [Related]

  • 7. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.
    Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D.
    Clin Sci (Lond); 1996 May 02; 90(5):393-401. PubMed ID: 8665777
    [Abstract] [Full Text] [Related]

  • 8. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.
    Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G.
    Am J Kidney Dis; 1999 Oct 02; 34(4):626-32. PubMed ID: 10516341
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G.
    Am J Kidney Dis; 1998 Mar 02; 31(3):453-63. PubMed ID: 9506682
    [Abstract] [Full Text] [Related]

  • 10. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
    Bos H, Henning RH, De Boer E, Tiebosch AT, De Jong PE, De Zeeuw D, Navis G.
    Kidney Int; 2002 Feb 02; 61(2):473-80. PubMed ID: 11849387
    [Abstract] [Full Text] [Related]

  • 11. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model.
    Benigni A, Zoja C, Noris M, Corna D, Benedetti G, Bruzzi I, Todeschini M, Remuzzi G.
    Am J Kidney Dis; 1999 Apr 02; 33(4):746-53. PubMed ID: 10196019
    [Abstract] [Full Text] [Related]

  • 12. Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition?
    Bos H, Henning RH, De Jong PE, De Zeeuw D, Navis G.
    Nephrol Dial Transplant; 2002 May 02; 17(5):793-7. PubMed ID: 11981065
    [Abstract] [Full Text] [Related]

  • 13. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C, Benigni A, Camozzi D, Corna D, Longaretti L, Todeschini M, Remuzzi G.
    Kidney Int; 2003 Sep 02; 64(3):857-63. PubMed ID: 12911535
    [Abstract] [Full Text] [Related]

  • 14. Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.
    Cao Z, Burrell LM, Tikkanen I, Bonnet F, Cooper ME, Gilbert RE.
    Kidney Int; 2001 Aug 02; 60(2):715-21. PubMed ID: 11473654
    [Abstract] [Full Text] [Related]

  • 15. Hyperlipidemia is secondary to proteinuria and is completely normalized by angiotensin-converting enzyme inhibition in hypertensive fawn-hooded rats.
    Verseput GH, Provoost AP, van Tol A, Koomans HA, Joles JA.
    Nephron; 1997 Aug 02; 77(3):346-52. PubMed ID: 9375831
    [Abstract] [Full Text] [Related]

  • 16. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.
    Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A.
    Am J Physiol Renal Physiol; 2009 Nov 02; 297(5):F1448-56. PubMed ID: 19675181
    [Abstract] [Full Text] [Related]

  • 17. Sodium restriction potentiates the renoprotective effects of combined vitamin D receptor activation and angiotensin-converting enzyme inhibition in established proteinuric nephropathy.
    Mirkovic K, Frenay AS, van den Born J, van Goor H, Navis G, de Borst MH, NIGRAM consortium.
    Nephrol Dial Transplant; 2017 Aug 01; 32(8):1293-1301. PubMed ID: 26311058
    [Abstract] [Full Text] [Related]

  • 18. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
    Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G.
    Am J Physiol; 1994 Dec 01; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
    [Abstract] [Full Text] [Related]

  • 19. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease.
    Remuzzi A, Gagliardini E, Sangalli F, Bonomelli M, Piccinelli M, Benigni A, Remuzzi G.
    Kidney Int; 2006 Apr 01; 69(7):1124-30. PubMed ID: 16395266
    [Abstract] [Full Text] [Related]

  • 20. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study.
    Janssen JJ, Gans RO, van der Meulen J, Pijpers R, ter Wee PM.
    Am J Hypertens; 1998 Sep 01; 11(9):1074-9. PubMed ID: 9752892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.